This book analyzes policy fights about what counts as good evidence of safety and effectiveness when it comes to new health care technologies in the United States and what political decisions mean for patients and doctors.
* Helps readers to understand the political, economic, and ideological dimensions of disputes about health technology assessment and the implications of various policy approaches for patients and the health care system
* Includes discussion of disputes related to hot topics such as stem cell therapies, mammography screening, genomic tests, breast cancer drugs, and Hepatitis C medications
* Discusses interest group pressure on government from large pharmaceutical companies and medical device manufacturers
* Connects to current political rhetoric about speeding up the availability of technology
Number of pages: 215
You may also be interested in...
Please sign in to write a review